No more pens: what the 2009 Pharmaceutical Research and Manufacturer's Association code changes really mean

Abstract In 2002, new guidelines for interactions with the pharmaceutical industry and physicians were published as an official code of conduct. Adherence to the guidelines was voluntary, and there were no provisions for discipline to companies who did not subscribe to the code or who subscribed but...

Full description

Saved in:
Bibliographic Details
Published in:Clinics in dermatology Vol. 27; no. 4; pp. 346 - 349
Main Author: Meffert, Jeffrey J., MD
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-07-2009
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract In 2002, new guidelines for interactions with the pharmaceutical industry and physicians were published as an official code of conduct. Adherence to the guidelines was voluntary, and there were no provisions for discipline to companies who did not subscribe to the code or who subscribed but did not comply. Many of the code standards are routinely violated, sometimes egregiously, with many violations on easy display at national professional meetings. In response to further problems and complaints, tougher code standards—now famous for the specific ban on logo pens and coffee cups—were adopted in 2009. Subscription to the new code is voluntary, and there are no provisions for discipline or punishment for those companies who chose not to subscribe or who may violate its standards.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0738-081X
1879-1131
DOI:10.1016/j.clindermatol.2009.02.005